News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
10 27 2009 MedPlus® Provides Technology Solution to Enable Meaningful Data Sharing for Improved Health OutcomesMaggie Gunter, PhD, president of the New Mexico Health Information Collaborative (NMHIC), announced today that the organization has been...
-
10 26 2009 ChartMaxx® Delivers Benefits to Leading Hospitals Across the Entire Clinical Care SettingMedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that it has been...
-
10 20 2009 - Total revenues of $1.9 billion, up 3.9%Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the...
-
10 16 2009 Test runs on the 3M Integrated Cycler; Reflects first Simplexa™ branded molecular test kit from Focus DiagnosticsThe U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease...
-
10 07 2009 First saliva-based cardiovascular disease test from Quest Diagnostics identifies gene variants implicated in potentially lethal reaction to popular anti-clotting drugDNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel...